Exelixis, Inc. (NASDAQ:EXEL) Receives $26.29 Consensus Price

Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12 month price objective among […]

Related Keywords

United States , David Edward Johnson , Patrickj Haley , William Blair , Fisher Asset Management , Exelixis Inc , Fifth Third Bancorp , Barclays , Rise Advisors , Securities Exchange Commission , Third Bancorp , Contravisory Investment Management Inc , Nasdaq , Get Free Report , Director David Edward Johnson , Exchange Commission , Asset Management , Investment Management , Get Free , Exelixis Daily , Exelixis , Nasdaq Exel , Rexel , Medical , 30161q10 , Ratings , Consensus ,